Armando Anido

Armando Anido currently works at SCYNEXIS, Inc., as Independent Director from 2019, Auris Medical AG, as Director from 2016, and Malvern Consulting Group, Inc., as President.
Mr. Anido also formerly worked at Auxilium Pharmaceuticals LLC, as President, Chief Executive Officer & Director in 2011, NuPathe, Inc., as Chief Executive Officer & Director from 2012 to 2014, Zynerba Pharmaceuticals, Inc., as Chairman & Chief Executive Officer from 2014 to 2023, Adolor Corp., as Independent Director in 2011, Life Sciences Pennsylvania, as Director, Aviragen Therapeutics, Inc., as Independent Non-Executive Director from 2015 to 2018, Respira Therapeutics, Inc., as Independent Director from 2012 to 2014, Auris Medical Holding AG, as Independent Non-Executive Director, Altamira Therapeutics Ltd., as Non-Executive Director, MedImmune LLC, as Executive Vice President-Sales & Marketing from 1999 to 2006, Glaxo Wellcome, Inc., as Vice President-Central Nervous System Marketing from 1995 to 1999, and Lederle Laboratories, as Vice President-AntiInfectives from 1989 to 1995.
Mr. Anido received his undergraduate degree and Masters Business Admin degree from West Virginia University.